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for colour-selected one-pot gold nanoparticle
syntheses†
M. Tanaka, a Y. Takahashi,a L. Roach,b K. Critchley,b S. D. Evansb and M. Okochi *aBiomineralisation peptides that facilitate the one-pot synthesis of gold
nanoparticles (AuNPs) with selected optical properties, were screened
using a coherent peptide-spotted array consisting of a AuNP binding
peptide library. As the biomineralised AuNPs were captured on each
peptide spot, analysis of the images provided information on their
collective optical properties.Living organisms produce nely tuned biomineral architectures
with the aid of biomineral-associated molecules.1,2 In contrast,
syntheses of inorganic nanoparticles (NPs) are generally per-
formed under relatively severe conditions such as high
temperature, high pressure, or extreme pH, and require the
presence of various harsh reagents, such as strong reducing/
oxidising agents and surfactants. Therefore, the use of
biomolecules in NP syntheses has received attention as
a potential ‘green synthesis’ vehicles for the morphological and
functional regulation of inorganic nanomaterials.3–5
Amongst the plethora of available biological molecules,
peptides have attracted particular attention as valuable tools in
bionanotechnology,6–12 because of their diverse functionalities
and, with certain peptides, the potential for specic binding to
particular materials (both organic and inorganic).13–15 Various
peptides have been utilised in the functionalisation of nano-
materials,13,16,17 the control of NP synthesis,18,19 as biotemplating
for morphological control,20 and biocatalysts for the NP crys-
talisation.6,21–23 The catalytic peptides used for NP synthesis,
named biomineralisation peptides, generally demonstrate high
specic binding to a target material, and are screened from
a peptide library (e.g. phage display library).5,24 However, the
properties of NPs synthesised, using such biomineralisation
peptides, cannot be predicted from screening process; thus theineering, Tokyo Institute of Technology,
-8552, Japan. E-mail: okochi.m.aa@m.
-3-5734-2116
y of Leeds, Leeds, LS2 9JT, UK
tion (ESI) available. See DOI:
hemistry 2019development of a rational peptide screening method which can
be used to synthesise NPs with specic morphological and
optical properties would greatly expand the potential of bio-
mineralisation peptides.
Here, we report a novel approach for the identication of
biomineralisation peptides suitable for the synthesis of NPs
with selected optical properties. In this study, as a model, gold
NPs (AuNPs) were investigated due to their highly stable surface
and localized surface plasmon resonance (LSPR) in the visible
spectrum; the latter allows colour evaluation of synthesised
NPs.25,26 The wavelength of the AuNP LSPR is dependent on the
shape, size, and agglomeration state.27–29 The peptide screening
technique uses a coherent membrane-supported peptide array
library30,31 consisting of AuNP binding peptides.32 Each spot was
able to capture synthesised AuNPs and through the accompa-
nying colour change indicate the unique optical properties of
bound AuNPs (Fig. 1). The use of this strategy provides a simple
and eﬀective technique to screen biomineralisation peptides for
the synthesis of AuNPs with selected optical properties in
ambient condition.
The schematic ow for AuNP mineralisation peptide
screening is shown in Fig. S1.† In a previous study, weFig. 1 Schematic illustration of peptide screening for colour selected
one-pot AuNPs biomineralisation.
Nanoscale Adv., 2019, 1, 71–75 | 71
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View Article Onlinedeveloped a technique for the screening of AuNP-binding
peptides by designing an array based on varying the amino
acid frequency informed by empirical results.32 This simple
strategy revealed a list of approximately 1800 peptides with
various AuNP binding aﬃnities. Herein, we evaluated the bio-
mineralisation property of the top two hundred high-binding
peptide sequences (ESI Table 1†). Various biomineralisation
peptides have previously been isolated from peptides strongly
bound to target nanocrystals.5,24 Consideration of the chemical
equilibrium of metallic ions and their crystalline NPs in solu-
tion, suggests that the strong binding of peptides stabilises the
crystals, resulting in a shi of equilibrium from ionic state
towards that of the crystal; i.e. the mineralisation of target
crystal is induced by the presence of the peptide.33 In addition,
it is known that crystal binding molecules potentially regulate
crystal morphology by enhancing and/or interfering with their
growth at random and/or specic crystal facets.24,34–36 Hence,
biomineralisation peptides can be screened eﬀectively from
a library of AuNP binding peptides, and synthesised particles
are expected to show various optical properties derived from
diﬀerent peptide-regulated particle morphologies.
Aer 1 h incubation of the peptide array in an aqueous
solution of 0.5 mM AuCl4
 in Tris-buﬀered saline (pH 7.4),
individual peptide array spots were observed to change colour,
indicative of AuNP biomineralisation. The observed colours
included yellow, red, pink, orange, and purple (Fig. 2). Several
spots containing peptides such as AuP90: NLWMQGGIML,
AuP94: SMWGTTQGHT, AuP59: MPWESHEISE, AuP80:
GGWHKLDESE, and AuP156: GHWQEIGDGV showed no colour
change. The characteristic colour of each peptide spot from the
scanned image (Canon, LiDE220), was evaluated using ImageJ
soware, based on their red (R), green (G) and blue (B) inten-
sities. The red chromaticity value (Cr) for each peptide spot was
calculated as Cr¼ R/(R + G + B). The green and blue chromaticity
values were also calculated as Cg ¼ G/(R + G + B) and Cb ¼ B/(R +
G + B), respectively. Aer listing the top twenty peptides of each
colour for red, green and blue AuNP biomineralisation spots,
secondary, the list was sorted by cumulative RGB intensity for
the selection of high biomineralisation activity. As (R, G, B)¼ (0,
0, 0) and (R, G, B) ¼ (255, 255, 255) correspond to zero intensity
(black) and maximum intensity (white) respectively. Peptides
demonstrating strong biomineralisation are signied by a lowFig. 2 Peptide array for screening of AuNP biomineralisation peptides.
The library comprises 200 AuNP binding peptides that were previously
screened. From the image analysis, the three highest intensity red,
green and blue peptide spots have been circled.
72 | Nanoscale Adv., 2019, 1, 71–75summed RGB value. In total, the R, G, and B top ten peptides
(re-named to R1–R10, G1–G10 and B1–B10 peptides, respec-
tively) and ten peptides showing the highest RGB value (no or
very weak biomineralisation, N1–N10 peptides) were listed with
their physicochemical properties in ESI Table 2.† In addition,
comparative analyses of amino acid frequency and amino acid
sequence in the top ten peptides were shown in Fig. S2 and S3.†
Comparison of the amino acid frequency with the average of all
200 peptides in the library showed a signicantly higher
proportion of tryptophan monomers in R peptides, whilst being
notably reduced in the bottom ten. As the number of tryptophan
in the top ten G and B peptides was a similar high-level with the
average of all 200 peptides, the residue would be prerequisite
for all AuNP biomineralisation peptides. It is probable that this
results from the indole structure of tryptophan, which can
reduce Au(III) to Au(0).37 The large number in R peptides
suggests that the biomineralisation of AuNPs showing red
colour requires strong Au(III) reducing property. It is curious
that histidine is increased in R and G peptides, whilst it is
decreased in B peptides. In previous work, the presence of
histidine in a biomineralisation peptide (AuP1) was found to
reduce AuNP biomineralisation activity.32 As the histidine
residue is generally known to chelate metallic ions, the binding
between AuCl4
 and histidine might restrict Au biomineralisa-
tion to form large particles due to steric hindrance, electrostatic
interactions, or both. Therefore, the small number of histidine
residues may be important in regulating the continuous bio-
mineralisation in the synthesis of larger AuNPs with resonances
showing blue colour. In addition, three peptides out of top ve
G peptide sequence have a unique motif, histidine (H)–isoleu-
cine–tryptophan (HIW; G1, G3 and G4), whilst there are no HIW
motif in other top ten sequences (Table S2†). The inclusion of
amino acids associated with both the induction and restriction
of AuNP biomineralisation in the motif may be important for
green colour AuNP syntheses. Acidic amino acids, D (aspartic
acid) and E (glutamic acid) were increased in negative and G
peptides. As the G peptides biomineralised smaller AuNPs than
R and B (see Fig. 4), the electrostatic repulsion between acidic
amino acid and AuCl4
 may weaken the biomineralisation
activity to form small AuNPs (green) or none. This hypothesis is
supported by the averaged isoelectric point (pI) and GRAVY (the
grand average of the hydropathy value) (Table S2†). The
magnitudes of the pI and hydropathy value GRAVY showed the
following trends negative < green < blue < red and red < green <
blue < negative, respectively. Therefore, peptides with poor
biomineralisation properties were relatively acidic and hydro-
philic. In addition, regarding to amino acid sequence analysis
by logo, R peptides surprisingly showed a unique character that
all ten peptides have tryptophan residue at 4th position from N-
terminus, while no tryptophan was found at same position in
other peptides listed in Table S2.† Although the reason is
unknown thus far, the position of a key amino acid, tryptophan,
for AuNP biomineralisation appears to regulate NP size
producing the observed red colour.
The top three R, G and B peptides that were screened from
the peptide array were investigated for use in the one-pot
synthesis of AuNPs in free solution. In the presence of eachThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinepeptide (0.2 mM) and AuCl4
 (0.5 mM), AuNPs of diﬀerent
colours were synthesised (Fig. 3). As expected, the observed
colours were consistent with the observed colours seen in the
peptide array, with the exception of the B1 peptide. The min-
eralisation by B1 peptide may be aﬀected by the presence of the
cellulose membrane (e.g. dispersibility). R peptides showed
a peak at 515 nm (red colour) in UV-Vis spectrum. This is well-
known peak derived from LSPR, however, R3 showed no peaks –
only an extinction curve consistent with scattering. The R3 and
G3 peptides revealed white dimmed colour aer addition of the
AuCl4
 solution. This is probably the result of molecular asso-
ciation between the peptide and AuCl4
 in this condition,
concealing the weak absorbance peak for R3. All G peptides
showed no peak, but the colour is clearly diﬀerent with the
sample containing only AuCl4
 (no peptide). When AuNP sizes
reduce down to <3 nm (called Au nanocluster), the plasmon
resonance band is signicantly weaker.21,38 Therefore, it seems
probable that these G peptides biomineralised ultra small
AuNPs which is supported by transmission electron microscope
(TEM) observations (Fig. S4†). In addition, B2 and B3 seemed to
be purple in colour. In the UV-Vis spectra of these samples
showed absorbance peaks (535 nm and weak peak at around
620 nm), especially in the case of peptide B3. As the absorbance
peak at around 530 nm and 600 nm shows red and blue colour,
the mixed purple colour is derived from a bimodal distribution
of AuNPs.
The AuNPs biomineralised by the top three R, G and B were
observed by TEM (Fig. S4†). As found in TEM images, the sizeFig. 3 Evaluation of colour selected AuNP biomineralisation by
screened peptides. Left images show the UV-Vis spectrum of each
samples and right images show the vials after the biomineralisation
reaction.
This journal is © The Royal Society of Chemistry 2019distribution was diﬀerent in each sample (green < red < blue).
The AuNP sizes synthesised by all three G and R peptides were
found to have average diameters of approximately 3 nm and
10 nm, respectively. Some precipitates were found in vials in the
presence of R3 and all G peptides (G1, 2, and 3), and were
observed unique particle aggregates or coral-like shape,
respectively (Fig. S5†). On the other hand, B peptides revealed
wider distributions with relatively larger sizes. In the case of B1
peptide, while the size range was similar with other B peptides
(B2 and B3), aggregated particles were frequently found. This
could explain the unique colour displayed by AuNPs bio-
mineralised by B1. The AuNPs biomineralised by R and G
peptides are mostly spherical, while AuNPs biomineralised by
B3 showed unique morphologies such as triangular and
hexagonal plates and decahedron. The surfaces of such parti-
cles are dominated by {111} crystal facets,39,40 suggesting that
the peptide is capable of selectively stabilizing individual facets
and hence could potentially be used in the controlled formation
of complex AuNP morphologies. Such particles will contribute
directly to the unique extinction spectra. It is well known, that
by comparison with spherical AuNPs, that SPR of such
morphologies can be signicantly red-shied.39–41
The time evolution of AuNPs during the synthesis were
further characterised by UV-Vis in the presence of diﬀerent
peptide concentrations (Fig. 3 and S6†). R1, G1 and B3
peptides were used due to their high colour intensity (see
Fig. 3) and the consideration of peptide solubility (R2 and G3
peptides require DMSO for solubilisation). As found in
Fig. S5,† AuNPs biomineralised by G1 showed no plasmon
band for whole time at any peptide concentrations (0.25–1.0
mM). In the presence of R1 peptide, the biomineralisation
reaction was almost completed within 15 min in all concen-
trations, whilst the reactions by peptide of B3 proceeded until
around 10 h. The diﬀerence in reaction kinetics is a key factor
in formation of diﬀerent sizes and morphology of AuNPs.42–44
This phenomenon has been recorded on video (ESI Movie 1†).
Whilst the red colours synthesised by peptides of R1 and B3
were similar for approximately the rst 30 min, only sample
B3 gradually changed colour to purple. The AuNPs syn-
thesised by B3 showed a unique absorbance spectrum,
compared to those synthesised by R1. Under high concen-
tration of B3, a near infrared (NIR) peak emerged at 755 nm,
which is probably derived from the LSPR of the triangular and
hexagonal plates.39,41 The size distributions of AuNPs bio-
mineralised by R1 and G1 at low concentration (0.2 mM)
(Fig. S4†) were similar those synthesised at 1 mM (Fig. 4).
However, AuNPs synthesised by B3 (1 mM) were larger and
well-featured rather than at lower concentration (0.25 and
0.5 mM) (Fig. S4†). Nanoplates are currently attracting
increased attention due to their high anisotropy with
enhanced cellular uptake45 and a strong plasmon band in the
NIR region that has great potential use in plasmonic photo-
thermal therapy, biosensing, cell imaging, and optical coating
for solar energy converters.39,41,46,47 Improvement in the shape
yield (currently <15%, Fig. 4C) would represent a signicant
benet to biomedical applications, because the synthesis
process is very simple, safe and environmentally-friendlyNanoscale Adv., 2019, 1, 71–75 | 73
Fig. 4 Representative transmission electronmicroscopy (TEM) images
of AuNPs biomineralised by colour selected AuNP synthesis peptides.
The average diameters were obtained by manual counting of more
than 200 particles in TEM images. Values shown at the bottom of each
image include SD.
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View Article Onlinewithout the requirement for harsh chemicals such as organic
solvents and surfactants.
Conclusions
In this study, we have developed a technique for the screening
of biomineralisation peptides for use in the “green” one-pot
synthesis of AuNPs with selected optical properties. Using
peptide array, the optical property information from bio-
mineralised AuNPs was collectively obtained through image
analysis. Subsequently, screened peptides were demonstrated
as suitable agents for the one-pot aqueous-phase synthesis of
AuNPs. Observed optical properties of synthesised particles
were consistent with those observed during peptide screening.
Through further optimization of the synthesis conditions, the
obtained AuNPs may nd use, particularly in biological appli-
cations, due to the simple and safe synthetic protocol, free of
toxic reagents. For example, green peptides seem to synthesize
Au nanoclusters and B3 peptide synthesize AuNPs showing
near-infrared absorbance. Materials with such properties are
already found and applied in biosensing, bioimaging and
therapeutics.21,25,26,47 These techniques are show potential not
only in improved AuNP biomineralisations, but also could be
used in the synthesis of other inorganic nanomaterials, such as
semiconductor and magnetic particles.
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